Top Markets
Coin of the day
DNA Chip Research Inc. DNA Chip Research Inc.

DNA Chip Research Inc.

2397
Clasificación en acciones #25565
Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the... Headquartered in Tokyo, Japan, DNA Chip Research Inc. specializes in the creation of DNA microarrays. Its operations encompass research and development, bespoke contract research, and comprehensive diagnostic assistance. A notable product is the Tbone EX Kit, supplied to forensic laboratories across Japan, including those within law enforcement agencies and academic institutions. Furthermore, the company is behind the development of the EGFR (epidermal growth factor receptor) Liquid gene analysis software, a diagnostic tool designed to identify mutations in the EGFR-encoding gene from DNA harvested from plasma or cancerous tissues. This software also assesses the effectiveness of EGFR tyrosine kinase inhibitors for individuals suffering from non-small cell lung cancer. Beyond this, they are actively engaged in creating a comprehensive gene panel for cancer screening through advanced sequencing technologies. Established in 1999, the firm operates out of Tokyo, Japan.
Precio por acción
$7.12
Última sincronización: 2025-06-18
Capitalización bursátil
$48.17M
Cambio (1 día)
-5.48%
Cambio (1 año)
0.00%
País
JP
Comercio DNA Chip Research Inc. (2397)

Categoría

Ganancias de DNA Chip Research Inc. (2397)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di DNA Chip Research Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de DNA Chip Research Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.58B -
US